Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
Andrew S. Chi(NYU Langone Health), Rohinton S. Tarapore(Oncoceutics (United States)), Matthew D. Hall(Miami Heart Research Institute), Nicole Shonka(University of Nebraska Medical Center), Sharon L. Gardner(NYU Langone Health), Yoshie Umemura(University of Michigan), Ashley Sumrall(Levine Cancer Institute), Ziad Khatib(Miami Children's Hospital), Sabine Mueller(University of California, San Francisco), Cassie Kline(University of California, San Francisco), Wafik Zaky(The University of Texas MD Anderson Cancer Center), Soumen Khatua(The University of Texas MD Anderson Cancer Center), Shiao-Pei Weathers(The University of Texas MD Anderson Cancer Center), Yazmín Odia(Miami Heart Research Institute), Toba N. Niazi(Miami Children's Hospital), Doured Daghistani(Miami Children's Hospital), Irene Cherrick(SUNY Upstate Medical University), David N. Korones(University of Rochester), Matthias A. Karajannis(Memorial Sloan Kettering Cancer Center), Xiao-Tang Kong(University of California, Irvine), Jane E. Minturn(Children's Hospital of Philadelphia), Angela J. Waanders(Children's Hospital of Philadelphia), Isabel Arillaga-Romany(Massachusetts General Hospital), Tracy T. Batchelor(Massachusetts General Hospital), Patrick Y. Wen(Dana-Farber Brigham Cancer Center), Krystal Merdinger(Oncoceutics (United States)), Lee Schalop(Oncoceutics (United States)), Martin Stogniew(Oncoceutics (United States)), Joshua E. Allen(Oncoceutics (United States)), Wolfgang Oster(Oncoceutics (United States)), Minesh P. Mehta(Baptist Hospital of Miami)
Cited by 194
Abstract
Related Papers
No related papers found
Powered by citation graph analysis